These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19251828)

  • 41. The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
    Kellner M; Muhtz C; Demiralay C; Husemann J; Koelsch W; Yassouridis A; Wiedemann K
    J Psychiatr Res; 2009 Mar; 43(6):642-8. PubMed ID: 18930474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose citalopram as a 5-HT neuroendocrine probe.
    Attenburrow MJ; Mitter PR; Whale R; Terao T; Cowen PJ
    Psychopharmacology (Berl); 2001 May; 155(3):323-6. PubMed ID: 11432696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Escitalopram-associated mania in a child.
    Kul M; Kilincaslan A; Yumru M; Kandemir H; Adaletli H; Ceylan MF
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):119-20. PubMed ID: 18294096
    [No Abstract]   [Full Text] [Related]  

  • 44. A case with euprolactinemic galactorrhea induced by escitalopram.
    Gulsun M; Algul A; Semiz UB; Ates MA; Doruk A; Ebrinc S; Basoglu C; Cetin M
    Int J Psychiatry Med; 2007; 37(3):275-8. PubMed ID: 18314855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Escitalopram versus placebo in the treatment of dysthymic disorder.
    Hellerstein DJ; Batchelder ST; Hyler S; Arnaout B; Toba C; Benga I; Gangure D
    Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prescribe escitalopram instead of citalopram.
    Keller DL
    Am J Med; 2013 Jun; 126(6):e21. PubMed ID: 23684405
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study.
    Kim JS; Lee EJ; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S;
    Lancet Psychiatry; 2017 Jan; 4(1):33-41. PubMed ID: 28012485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study.
    Davidson JR; Bose A; Korotzer A; Zheng H
    Depress Anxiety; 2004; 19(4):234-40. PubMed ID: 15274172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Citalopram, escitalopram, and the QT interval.
    Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918
    [No Abstract]   [Full Text] [Related]  

  • 52. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tapping the potential of isomer science.
    Enos G
    Behav Healthc Tomorrow; 2002 Feb; 11(1):SR30-1. PubMed ID: 11837139
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - a secondary outcome analysis from the randomized AGENDA trial.
    Knorr U; Koefoed P; Gluud C; Wetterslev J; Winkel P; Gether U; Vinberg M; Kessing LV
    Nord J Psychiatry; 2016; 70(4):297-302. PubMed ID: 26752119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Escitalopram-associated serotonin toxicity.
    Vari G; Beckson M
    J Clin Psychopharmacol; 2007 Apr; 27(2):229-30. PubMed ID: 17414259
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of endocrine profile and hypothalamic-pituitary-testis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction.
    Safarinejad MR
    J Clin Psychopharmacol; 2008 Aug; 28(4):418-23. PubMed ID: 18626269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Escitalopram attenuates fear stress-induced increase in amygdalar dopamine following methamphetamine-induced sensitisation: Implications of fine-tuning action of selective serotonin reuptake inhibitors on emotional processing.
    Muraoka H; Oshibuchi H; Kawano M; Kawano T; Tsutsumi T; Yamada M; Ishigooka J; Nishimura K; Inada K
    Eur J Pharmacol; 2018 Sep; 834():1-9. PubMed ID: 29981749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Escitalopram for treatment of night eating syndrome: a 12-week, randomized, placebo-controlled trial.
    Vander Wal JS; Gang CH; Griffing GT; Gadde KM
    J Clin Psychopharmacol; 2012 Jun; 32(3):341-5. PubMed ID: 22544016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.